3 items

Very low-dose Avastin effective for preventing blindness in preterm infants

April 23, 2020

Babies born prematurely who require treatment to prevent blindness from retinopathy of prematurity (ROP) could be treated with a dose of Avastin (bevacizumab) that is a fraction of the dose commonly used for ROP currently.

AI may help spot newborns at risk for most severe form of blinding disease

March 4, 2020

An artificial intelligence (AI) device that has been fast-tracked for approval by the Food and Drug Administration may help identify newborns at risk for aggressive posterior retinopathy of prematurity (AP-ROP). AP-ROP is the most severe form of ROP.

Tech that detects cause of preemie blindness gets federal nod

January 30, 2020

An artificial intelligence algorithm that can detect a potentially devastating cause of childhood blindness better than most human experts has been granted breakthrough status by the FDA.